PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15541015-5	2004	5 The S1P3 receptor antagonist suramin (100 microM) significantly inhibited responses to S1P and SPC in rats but not in mice, and did not affect noradrenaline responses in either species.	Suramin	31-38	sphingosine-1-phosphate receptor 1	Mus musculus	6-9	
15541015-8	2004	Responses to S1P and SPC differ between both species with regard to suramin-sensitivity indicating involvement of different receptor subtypes for lysosphingolipids in both species.	Suramin	68-75	sphingosine-1-phosphate receptor 1	Mus musculus	13-16	
8665846-5	1996	As with LPA, S1P action is inhibited by suramin and subject to homologous desensitization; however, the responses to S1P and LPA do not show cross-desensitization.	Suramin	40-47	sphingosine-1-phosphate receptor 1	Mus musculus	13-16	
21145832-12	2011	Furthermore, the effect of S1P was mimicked by SEW2871 (an S1P(1) agonist), and blocked by suramin (an S1P(3) antagonist) and by silencing S1P(1,3) expression.	Suramin	91-98	sphingosine-1-phosphate receptor 1	Mus musculus	27-30	
14870969-8	2003	Suramin (200 microM) significantly reduced, by approximately 90%, the effects of S1P on ICM and I(Ca), suggesting that most of S1P action occurred via Edg-3Rs.	Suramin	0-7	sphingosine-1-phosphate receptor 1	Mus musculus	81-84	
14870969-8	2003	Suramin (200 microM) significantly reduced, by approximately 90%, the effects of S1P on ICM and I(Ca), suggesting that most of S1P action occurred via Edg-3Rs.	Suramin	0-7	sphingosine-1-phosphate receptor 1	Mus musculus	127-130